Paytient and Mark Cuban Cost Plus Drug Company Team Up to Help People Find--and Pay for--Lower-Cost Prescriptions

11.09.25 15:04 Uhr

COLUMBIA, Mo., Sept. 11, 2025 /PRNewswire/ -- Paytient, a leader in innovative employer and insurer payment solutions that make healthcare more affordable has teamed up with Mark Cuban Cost Plus Drug Company, PBC to give employees at nearly 7,000 employers the ability to effortlessly pay less for care.

Paytient’s Health Payment Account (HPA) empowers people to pay for care over time with no interest and no fees — ever. (PRNewsfoto/Paytient)

Paytient members can now see transparent, low-cost cash prices for medications in their app, making it easier to save money and time. Members can also choose to spread their out-of-pocket costs over time with no interest or fees.

"This is what a human-centered healthcare shopping experience should look like—simple, transparent, and accessible," said Alex Oshmyansky, CEO of Mark Cuban Cost Plus Drug Company. "People deserve to know the lowest price for their medication, right at their fingertips, and have the flexibility to pay for it however they want. And when that lowers the cost of care overall, employers benefit too."

Paytient's own self-funded health plan illustrates the opportunity.

"In 2024, our employees filled more than 1,000 generic prescriptions," said Brian Whorley, founder and CEO of Paytient. "On average, each employee paid $14 out of pocket, while our health plan paid another $27 per script. Many of those medications could have been purchased through Mark Cuban Cost Plus Drugs for less—even with shipping. We consider that $27 per script as our employees' money that we could have been saved and I much rather have paid it to our employees instead of sending it out the door for overpriced care. The point is this: when the health plan overpays for care, you're wasting your employees' hard-earned compensation and you're giving it to businesses who are price gouging your people in a moment of need. I'll rage against that machine all day, every day. This is about treating our employees' compensation with care and respect, and we do that by simply giving people an easier way to pay a fair market price."

Together, Paytient and Mark Cuban Cost Plus Drugs are working to enable employers and employees to pay less for care - one prescription at a time.

"The missing innovation in healthcare is the one that helps more people pay lower prices. It's the prices we pay—and how we pay them— that matter to most of us on Main Street," Whorley added. "The good news is that more people, and their employers, are waking up to the savings, privacy, and honesty of simply paying cash."

About Paytient
7,000 employers and health plans are offering Paytient as a benefit to ensure nearly 23 million Americans can more easily pay for care. Paytient gives people the ability to more easily self-pay for care—improving access, ensuring affordability and creating plan savings for employers and insurers.

About Mark Cuban Cost Plus Drug Company, PBC
The Mark Cuban Cost Plus Drug Company, PBC (Cost Plus Drugs) aims to fundamentally change the way the pharmaceutical industry operates. As a public-benefit corporation, its social mission of improving public health is just as important as the bottom line. Cost Plus Drugs transparently charges a standard markup on every drug it sells. The costplusdrugs.com online pharmacy launched in January 2022 now carries over 2,300 prescription products, delivered by mail to thousands of happy customers every day. Customers can also go to participating retail pharmacies to receive Cost Plus Drugs pricing through the Team Cuban Card. Cost Plus Drugs is working with health plans, managed-care organizations, pharmacy benefits managers (PBMs) and self-insured employers to bring these same savings to employer-sponsored benefit plans nationwide.

Cision View original content to download multimedia:https://www.prnewswire.com/news-releases/paytient-and-mark-cuban-cost-plus-drug-company-team-up-to-help-people-findand-pay-forlower-cost-prescriptions-302552843.html

SOURCE Paytient